LTBSLet the Bible Speak (various organizations)
LTBSLiver Toxicology Biomarker Study
References in periodicals archive ?
The first phase of the LTBS, which will last approximately nine months, has been designed by the FDA and BG Medicine with input from leading academic and industry scientists.
The LTBS has been designed by FDA and BG Medicine with input from other pharmaceutical companies and will be conducted, with their collaboration, at the NCTR laboratory in Jefferson, Ark.
The LTBS will be conducted at the FDA's NCTR laboratory in Jefferson, Arkansas and at BG Medicine in Waltham, Massachusetts.